CHEBI:71023 - alcaftadine

ChEBI IDCHEBI:71023
ChEBI Namealcaftadine
Stars
DefinitionAn imidazobenzazepine that is 6,11-dihydro-5H-imidazo[2,1-b][3]benzazepine substituted at position 3 by a formyl group and at position 11 by a 1-methylpiperidin-4-ylidene group. An antihistamine used for treatment of allergic conjunctivitis.
Last Modified22 February 2017
SubmitterSteve
DownloadsMolfile
FormulaC19H21N3O
Net Charge0
Average Mass307.397
Monoisotopic Mass307.16846
SMILES[H]C(=O)c1cnc2n1CCc1ccccc1C2=C1CCN(C)CC1
InChIInChI=1S/C19H21N3O/c1-21-9-6-15(7-10-21)18-17-5-3-2-4-14(17)8-11-22-16(13-23)12-20-19(18)22/h2-5,12-13H,6-11H2,1H3
InChIKeyMWTBKTRZPHJQLH-UHFFFAOYSA-N
Wikipedia
Roles Classification
Chemical Role:
Bronsted base  A molecular entity capable of accepting a hydron from a donor (Brønsted acid).
Biological Role:
H1-receptor antagonist  H1-receptor antagonists are the drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine.
Applications:
H1-receptor antagonist  H1-receptor antagonists are the drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine.
anti-allergic agent  A drug used to treat allergic reactions.
ChEBI Ontology
Outgoing Relation(s)
alcaftadine (CHEBI:71023) has role anti-allergic agent (CHEBI:50857)
alcaftadine (CHEBI:71023) has role H1-receptor antagonist (CHEBI:37955)
alcaftadine (CHEBI:71023) is a aldehyde (CHEBI:17478)
alcaftadine (CHEBI:71023) is a imidazobenzazepine (CHEBI:71024)
alcaftadine (CHEBI:71023) is a piperidines (CHEBI:26151)
alcaftadine (CHEBI:71023) is a tertiary amino compound (CHEBI:50996)
IUPAC Name 
11-(1-methylpiperidin-4-ylidene)-6,11-dihydro-5H-imidazo[2,1-b][3]benzazepine-3-carbaldehyde
INNs  Source
alcaftadineKEGG DRUG
alcaftadinumWHO MedNet
alcaftadinaWHO MedNet
alcaftadineWHO MedNet
Brand Name  Source
LastacaftKEGG DRUG
Manual XrefsDatabases
D06552KEGG DRUG
US2008139531Patent
WO2007117971Patent
US5468743Patent
DB06766DrugBank
HMDB0015670HMDB
AlcaftadineWikipedia
US2012094978Patent
MX2008012657Patent
CN101460176Patent
US2008051385Patent
KR20080110881Patent
4165DrugCentral
Registry NumbersSources
Reaxys:13759211Reaxys
CAS:147084-10-4KEGG DRUG
CAS:147084-10-4ChemIDplus
Citations